These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 32238510

  • 1. Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic Cohort.
    Urowitz MB, Gladman DD, Ibañez D, Su J, Mursleen S, Sayani A, Ross Terres JA, Iczkovitz S.
    J Rheumatol; 2021 Jan 01; 48(1):67-73. PubMed ID: 32238510
    [Abstract] [Full Text] [Related]

  • 2. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
    Gatto M, Saccon F, Zen M, Regola F, Fredi M, Andreoli L, Tincani A, Urban ML, Emmi G, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Tani C, Mosca M, Ubiali T, Gerosa M, Bozzolo E, Canti V, Cardinaletti P, Gabrielli A, Tanti G, Gremese E, De Marchi G, De Vita S, Fasano S, Ciccia F, Pazzola G, Salvarani C, Negrini S, Puppo F, Di Matteo A, De Angelis R, Orsolini G, Rossini M, Faggioli P, Laria A, Piga M, Mathieu A, Scarpato S, Rossi FW, de Paulis A, Brunetta E, Ceribelli A, Selmi C, Prete M, Racanelli V, Vacca A, Bartoloni E, Gerli R, Larosa M, Iaccarino L, Doria A.
    Arthritis Rheumatol; 2020 Aug 01; 72(8):1314-1324. PubMed ID: 32275125
    [Abstract] [Full Text] [Related]

  • 3. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB, Ibañez D, Jerome D, Gladman DD.
    J Rheumatol; 2006 Nov 01; 33(11):2192-8. PubMed ID: 16981295
    [Abstract] [Full Text] [Related]

  • 4. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
    Lupus; 2016 Jun 01; 25(7):719-26. PubMed ID: 26821965
    [Abstract] [Full Text] [Related]

  • 5. Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre.
    Hill DD, Eudy AM, Egger PJ, Fu Q, Petri MA.
    Lupus Sci Med; 2021 Apr 01; 8(1):. PubMed ID: 33832976
    [Abstract] [Full Text] [Related]

  • 6. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
    Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A.
    Ann Rheum Dis; 2018 Jan 01; 77(1):104-110. PubMed ID: 28970217
    [Abstract] [Full Text] [Related]

  • 7. Serum uric acid is associated with damage in patients with systemic lupus erythematosus.
    Elera-Fitzcarrald C, Reátegui-Sokolova C, Gamboa-Cardenas RV, Medina M, Zevallos F, Pimentel-Quiroz VR, Cucho-Venegas JM, Alfaro-Lozano J, Rodriguez-Bellido Z, Pastor-Asurza CA, Perich-Campos RA, Alarcón GS, Ugarte-Gil MF.
    Lupus Sci Med; 2020 Jan 01; 7(1):e000366. PubMed ID: 32153795
    [Abstract] [Full Text] [Related]

  • 8. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
    Ugarte-Gil MF, Hanly J, Urowitz M, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen DL, Askanase A, Pons-Estel BA, Alarcón GS.
    Ann Rheum Dis; 2022 Nov 01; 81(11):1541-1548. PubMed ID: 35944946
    [Abstract] [Full Text] [Related]

  • 9. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
    Kim SK, Choe JY, Lee SS.
    J Rheumatol; 2017 Apr 01; 44(4):452-458. PubMed ID: 28298561
    [Abstract] [Full Text] [Related]

  • 10. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO, Corrente JE, Saad-Magalhães C.
    Lupus; 2016 Nov 01; 25(13):1479-1484. PubMed ID: 27230556
    [Abstract] [Full Text] [Related]

  • 11. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort.
    Urowitz MB, Gladman DD, Ibañez D, Fortin PR, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Sanchez-Guerrero J, Wallace DJ, Ginzler E, Alarcón GS, Merrill JT, Bruce IN, Sturfelt G, Nived O, Steinsson K, Khamashta M, Petri M, Manzi S, Ramsey-Goldman R, Dooley MA, van Vollenhoven RF, Ramos M, Stoll T, Zoma A, Kalunian K, Aranow C.
    Arthritis Care Res (Hoboken); 2012 Jan 01; 64(1):132-7. PubMed ID: 21954226
    [Abstract] [Full Text] [Related]

  • 12. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
    Bruce IN, O'Keeffe AG, Farewell V, Hanly JG, Manzi S, Su L, Gladman DD, Bae SC, Sanchez-Guerrero J, Romero-Diaz J, Gordon C, Wallace DJ, Clarke AE, Bernatsky S, Ginzler EM, Isenberg DA, Rahman A, Merrill JT, Alarcón GS, Fessler BJ, Fortin PR, Petri M, Steinsson K, Dooley MA, Khamashta MA, Ramsey-Goldman R, Zoma AA, Sturfelt GK, Nived O, Aranow C, Mackay M, Ramos-Casals M, van Vollenhoven RF, Kalunian KC, Ruiz-Irastorza G, Lim S, Kamen DL, Peschken CA, Inanc M, Urowitz MB.
    Ann Rheum Dis; 2015 Sep 01; 74(9):1706-13. PubMed ID: 24834926
    [Abstract] [Full Text] [Related]

  • 13. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB, Bae SC.
    Int J Rheum Dis; 2015 Feb 01; 18(2):117-28. PubMed ID: 25524656
    [Abstract] [Full Text] [Related]

  • 14. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
    Ibañez D, Gladman D, Urowitz M.
    J Rheumatol; 2007 Feb 01; 34(2):336-40. PubMed ID: 17183620
    [Abstract] [Full Text] [Related]

  • 15. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
    Medhat BM, Behiry ME, Sobhy N, Farag Y, Marzouk H, Mostafa N, Khalifa I, Elkhalifa M, Eissa BM, Hassan EHE.
    Clin Rheumatol; 2020 Feb 01; 39(2):435-442. PubMed ID: 31758421
    [Abstract] [Full Text] [Related]

  • 16. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.
    J Rheumatol; 2019 May 01; 46(5):492-500. PubMed ID: 30647177
    [Abstract] [Full Text] [Related]

  • 17. Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.
    Kim SK, Choe JY, Lee SS.
    Yonsei Med J; 2018 Sep 01; 59(7):857-864. PubMed ID: 30091319
    [Abstract] [Full Text] [Related]

  • 18. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).
    Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA, GLADEL.
    Ann Rheum Dis; 2017 Dec 01; 76(12):2071-2074. PubMed ID: 28939626
    [Abstract] [Full Text] [Related]

  • 19. Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis.
    Urowitz MB, Ohsfeldt RL, Wielage RC, Kelton KA, Asukai Y, Ramachandran S.
    Ann Rheum Dis; 2019 Mar 01; 78(3):372-379. PubMed ID: 30610066
    [Abstract] [Full Text] [Related]

  • 20. Damage accrual in systemic lupus erythematosus in Dominicans in New York City and the Dominican Republic.
    Geraldino-Pardilla L, Kapoor T, Canto I, Perez-Recio T, Then J, Tineo C, Loyo E, Askanase A.
    Lupus; 2018 Oct 01; 27(12):1989-1995. PubMed ID: 30092732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.